NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Otsuka Pharmaceutical Co., Ltd. 

2-9 Kanda Tsukasa-cho
Chiyoda-ku
Tokyo    101-8535  Japan
Phone: 03-3292-0021 Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Penwest Pharmaceutical (PPCO) Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical Co., Ltd. 10/28/2009 8:23:30 AM    More...
MethylGene Issues Shares to Otsuka Pharmaceutical Co., Ltd. 10/21/2009 1:24:45 PM    More...
MethylGene Announces Equity Investment From Otsuka Pharmaceutical Co., Ltd. 10/15/2009 9:45:52 AM    More...
MethylGene and Otsuka Pharmaceutical Co., Ltd. Extend Funded Research Collaboration; Methylgene Could get up to $50.5 Million 9/9/2009 6:53:08 AM    More...
Penwest Pharmaceutical (PPCO) Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical Co., Ltd. 6/17/2009 10:02:00 AM    More...
Otsuka Pharmaceutical Co., Ltd.: FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5/22/2009 7:32:08 AM    More...
Penwest Pharmaceutical (PPCO) Enters Into Second Research and Development Agreement With Otsuka Pharmaceutical Co., Ltd. 11/25/2008 8:44:41 AM    More...
Galenea and Otsuka Pharmaceutical Co., Ltd. Extend & Expand Schizophrenia Research Collaboration Worth $75 Million 10/6/2008 6:50:13 AM    More...
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration 9/8/2008 11:59:15 AM    More...
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye 9/4/2008 6:39:26 AM    More...
1234567